Trilogy Capital Inc. Laboratory Corp Of America Holdings Transaction History

Trilogy Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$197.69 - $227.29 $43,689 - $50,231	-221 Reduced 17.4%	1,049 $238,000
Q3 2023 Oct 16, 2023	SELL	$201.05 - $221.7 $31,765 - $35,028	-158 Reduced 11.06%	1,270 $255,000
Q2 2023 Jul 24, 2023	BUY	$211.93 - $241.33 $26,067 - $29,683	123 Added 9.43%	1,428 $344,000
Q1 2023 Apr 17, 2023	BUY	$213.32 - $257.83 $278,382 - $336,468	1,305 New	1,305 $299,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.